Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 160,992 |
|
|||||
| News | - | ||||||
| Day High | 16.32 | Low High |
|||||
| Day Low | 13.65 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Avalo Therapeutics Inc | AVTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.78 | 5.49% | 14.98 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 13.95 | 13.65 | 16.32 | 14.98 | 14.20 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,108 | 160,992 | $ 15.26 | $ 2,455,944 | - | 3.9501 - 1,130.40 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:48:24 | 25 | $ 16.00 | USD |
Avalo Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.35M | 801.61k | - | 1.92M | -31.54M | -39.35 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Avalo Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AVTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 13.62 | 16.32 | 11.46 | 12.40 | 73,839 | 1.36 | 9.99% |
| 1 Month | 18.68 | 34.46 | 11.10 | 20.91 | 1,970,833 | -3.70 | -19.81% |
| 3 Months | 4.65 | 34.46 | 4.0101 | 19.35 | 714,549 | 10.33 | 222.15% |
| 6 Months | 26.40 | 34.46 | 3.9501 | 18.15 | 11,407,247 | -11.42 | -43.26% |
| 1 Year | 753.60 | 1,130.40 | 3.9501 | 33.38 | 23,585,672 | -738.62 | -98.01% |
| 3 Years | 688.80 | 1,711.20 | 3.9501 | 39.32 | 8,989,235 | -673.82 | -97.83% |
| 5 Years | 688.80 | 1,711.20 | 3.9501 | 39.32 | 8,989,235 | -673.82 | -97.83% |
Avalo Therapeutics Description
| Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing in development with ongoing clinical programs: AVTX-002, AVTX-007, and AVTX-006. |
